President, CEO: Jean-Claude Maurel – MD

Jean-Claude is the founder of Medesis Pharma and brings more than 30 years of experience in the research and development and commercialization of novel pharmaceutical product.

After founding in 1985, Natura Medica, a pharmaceutical company commercialising natural product assets, , the company was acquired in 1990 by Ipsen-Beaufour. In 1991, he created a research company that after 10 years of chemical and pharmacological explorations, discovered the lipid constituents which are today the basis of the Aonys® technology.

In 2003, he created Medesis Pharma by consolidating previous patents and know-how.

 

VP Investor Relations: Assad Singaby -MBA

Assad has 20 years of Investment banking and consulting experience with leading North American flagship banks. He has specialized in M&As and IPO’s for mid and large cap energy, chemical /petrochemical and pharmaceutical companies.

He holds an MEng in statistic and econometrics and an MBA.

 

CSO: Patrick Maurel – PhD

Patrick has a 40 years-experience as research director at INSERM, the French National Institute for Medical Research. He is world expert in the field of hepatology and more recently in hepatitis C infection with use of stem cells as biotherapies.

He is fellow of several scientific societies involved in virology and hepatology.

He holds a PhD in Biology and has authored 215 international publications.

Business Development: Peter Jackson – PhD

 Medical Affairs: Ivan Shaw – PhD